Nicole Mittmann

Canadian Agency for Drugs and Technologies in Health — Canada

Economics, Econometrics and Finance · Social Sciences

41h-index6.3kcitations268works20.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Health Systems, Economic Evaluations, Quality of Life(71), Economic and Financial Impacts of Cancer(55), Pancreatic and Hepatic Oncology Research(18), Global Cancer Incidence and Screening(18), Lung Cancer Treatments and Mutations(12)

Publications265 total

Using real-world, population-level data to assess the uptake of active surveillance for low-grade prostate cancer before and after the release of clinical guidelines
Canadian Urological Association Journal·2025· 1 citedOpen Access
Update to the PRISMA guidelines for network meta-analyses and scoping reviews and development of guidelines for rapid reviews: a scoping review protocol
JBI Evidence Synthesis·2025· 40 citedOpen Access
Healthcare and Cancer Treatment Costs of Breast Screening Outcomes among Higher than Average Risk Women
Current Oncology·2023· 1 citedOpen Access
Changes in Health Care Costs, Survival, and Time Toxicity in the Era of Immunotherapy and Targeted Systemic Therapy for Melanoma
JAMA Dermatology·2023· 34 citedOpen Access
Impact on costs and outcomes of multi-gene panel testing for advanced solid malignancies: A cost consequence analysis using linked administrative data.
Journal of Clinical Oncology·2023· 4 cited
Hospital encounters and associated costs of prostate evaluation for clinically important disease
Canadian Urological Association Journal·2023· 1 citedOpen Access
Quality of anticoagulant control and patient experience associated with long-term warfarin in Canadian patients with non-valvular atrial fibrillation: A multicentre, prospective study
PLoS ONE·2023· 3 citedOpen Access
Cost‐effectiveness of second‐line ipilimumab for metastatic melanoma: A real‐world population‐based cohort study of resource utilization
Cancer Medicine·2023· 4 citedOpen Access
Impact of Frailty on Health Care Resource Utilization and Costs of Care in Myelodysplastic Syndromes
JCO Oncology Practice·2023· 6 citedOpen Access
Reporting of tobacco use and tobacco-related analyses in cancer cooperative group clinical trials: a systematic scoping review
ESMO Open·2022· 6 citedOpen Access
Using Real-World Data to Determine Health System Costs of Ontario Women Screened for Breast Cancer
Current Oncology·2022· 2 citedOpen Access
Delayed intracranial hemorrhage after head injury among elderly patients on anticoagulation seen in the emergency department
Canadian Journal of Emergency Medicine·2022· 8 cited
How We Might Further Integrate Considerations of Environmental Impact When Assessing the Value of Health Technologies
International Journal of Environmental Research and Public Health·2022· 28 citedOpen Access
Post-Market Drug Evaluation
Canadian Journal of Health Technologies·2022Open Access
The Value of Patient Registries: Common Needs for Rare Diseases
Canadian Journal of Health Technologies·2022Open Access
Understanding the Portrait of Dementia Care in Canada: A CADTH Panel of Experts
Canadian Journal of Health Technologies·2022· 5 citedOpen Access
Platform, Basket, and Umbrella Trial Designs: Issues Around Health Technology Assessment of Novel Therapeutics
Canadian Journal of Health Technologies·2022· 6 citedOpen Access
Platform, Basket, and Umbrella Trial Designs: Stakeholder Perspectives of Novel Therapeutics
Canadian Journal of Health Technologies·2022Open Access
The FACT-8D, a new cancer-specific utility algorithm based on the Functional Assessment of Cancer Therapies-General (FACT-G): a Canadian valuation study
Health and Quality of Life Outcomes·2022· 15 citedOpen Access
A comparative study of patient-reported outcomes after contemporary radiation techniques for prostate cancer
Radiotherapy and Oncology·2022· 1 cited
page 1 of 14Next →

Frequent Co-authors

Neil H. Shear(11), Murray Krahn(7), Brian Chan(7), Simon R. Knowles(6), Soo Jin Seung(4), William K. Evans(4), Natasha B. Leighl(4), Thomas R. Einarson(3), Nathan Herrmann(3), Claudio A. Naranjo(3), Anita Rachlis(3), Sean B. Rourke(3), Kelvin Chan(3), Suzanne M. Cadarette(3), Nick Daneman(3), Pierre K. Isogai(3), Frances A. Shepherd(3), Daniel J. Kagedan(3), N. Goyert(3), Craig C. Earle(3)